Switch to:

Beam Therapeutics Marketable Securities

: $127.39 Mil (As of Mar. 2020)
View and export this data going back to 2020. Start your Free Trial

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Beam Therapeutics's marketable securities for the quarter that ended in Mar. 2020 was $127.39 Mil.

Beam Therapeutics's annual marketable securities stayed the same from Dec. 2017 ($0.00 Mil) to Dec. 2018 ($0.00 Mil) but then increased from Dec. 2018 ($0.00 Mil) to Dec. 2019 ($54.63 Mil).


Beam Therapeutics Marketable Securities Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Beam Therapeutics Annual Data
Dec17 Dec18 Dec19
Marketable Securities 0.00 0.00 54.63

Beam Therapeutics Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Marketable Securities Premium Member Only Premium Member Only 0.00 88.91 73.13 54.63 127.39

Beam Therapeutics Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Beam Therapeutics  (NAS:BEAM) Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' marketable securities also includes "Other Short Term Investment".



Beam Therapeutics Marketable Securities Related Terms


Beam Therapeutics Marketable Securities Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)